In its appeal from an adverse decision on priority by the Patent Trial and Appeal Board (PTAB) in Interference No. 106,115 (directed to CRISPR-mediated gene editing), Junior Party the.
The Patent Trial and Appeal Board (like its predecessor, the Board of Patent Appeals and Interferences or BPAI) occasionally renders an opinion having the tendency to raise an eyebrow.
/PRNewswire/ HAPPE Spine, an emerging leader in the development of next generation orthopedic and spinal implants enabled by the HAPPE™ material platform,.